Skip to main content
Top

Insomnıa ın Heart Faılure Patıents ın a Hospıtal Settıng: Causes, Consequences, and Interventıons

Published in:

Abstract

Purpose of Review

This review explores the causes, consequences, and management approaches of hospital-acquired insomnia in patients with heart failure (HF). It examines the key factors contributing to insomnia in hospitalized HF patients, its impact on health outcomes, and effective management strategies to address the issue.

Recent Findings

Recent research highlights that environmental factors (such as noise, lighting, and medical interventions) and clinical symptoms (including dyspnea and nocturia) significantly contribute to insomnia in hospitalized HF patients. Insomnia exacerbates HF symptoms, increasing hospitalization rates, healthcare costs, and the risk of cardiovascular complications. Non-pharmacological interventions have improved sleep quality and overall well-being, including Cognitive Behavioral Therapy for Insomnia (CBT-I), sleep hygiene education, and supervised exercise programs.

Summary

Hospital-acquired insomnia negatively affects both the physical and psychosocial health of HF patients. Effective management requires a multidisciplinary approach, incorporating both pharmacological and non-pharmacological strategies. Nurses play a crucial role in implementing sleep-promoting interventions. Creating a hospital environment that supports sleep, raising healthcare professionals’ awareness, and integrating evidence-based interventions can enhance recovery outcomes. Future research should focus on long-term studies evaluating the efficacy of insomnia management strategies in HF patients.
Title
Insomnıa ın Heart Faılure Patıents ın a Hospıtal Settıng: Causes, Consequences, and Interventıons
Authors
Mehmet Emin Atay
Bahar Çiftçi
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 1/2025
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-025-02256-1
This content is only visible if you are logged in and have the appropriate permissions.

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME